Finance

Lists
003850:KRX
Boryung Corp
â‚©9,280.00
+4.15%
(+370.00) 1D
Sep 11, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 003850...
Open
â‚©8,900
High
â‚©9,360
Low
â‚©8,820
Mkt. cap
796.11B
Avg. vol.
93.96K
Volume
0.00
Dividend
1.72%
Quarterly dividend
â‚©40
Ex-dividend date
Dec 27, 2023
P/E ratio
6.46
52-wk high
â‚©10,800
52-wk low
â‚©7,410
EPS
â‚©1,436
Shares outstanding
85.79M
No. of employees
1K
Open
â‚©8,900
High
â‚©9,360
Low
â‚©8,820
Mkt. cap
796.11B
Avg. vol.
93.96K
Volume
0.00
Dividend
1.72%
Quarterly dividend
â‚©40
Ex-dividend date
Dec 27, 2023
P/E ratio
6.46
52-wk high
â‚©10,800
52-wk low
â‚©7,410
EPS
â‚©1,436
Shares outstanding
85.79M
No. of employees
1K
About Boryung Corp
CEOJay Kim | Daniel Chang
Employees1.14K
FoundedOct 1, 1957
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
280.01B
245.35B
255.35B
279.62B
Cost of goods sold
176.73B
160.45B
160.77B
174.99B
Cost of revenue
176.73B
160.45B
160.77B
174.99B
Research and development expenses
15.58B
19.29B
12.83B
14.17B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
52.15B
58.49B
54.69B
57.21B
Operating expense
73.85B
85.55B
74.43B
80.84B
Total operating expenses
250.57B
246.00B
235.20B
255.82B
Operating income
29.44B
-648.67M
20.15B
23.80B
Other non operating income
-1.05B
-3.02B
-744.36M
-771.66M
EBT including unusual items
43.46B
18.69B
53.93B
31.62B
EBT excluding unusual items
41.80B
3.23B
47.06B
26.88B
Income tax expense
9.46B
-2.40B
12.49B
7.57B
Effective tax rate
21.77%
-12.82%
23.16%
23.93%
Other operating expenses
1.06B
2.82B
1.97B
2.10B
Net income
34.00B
21.09B
41.44B
24.05B
Net profit margin
12.14%
8.60%
16.23%
8.60%
Earnings per share
-
-
-
-
Interest and investment income
3.47B
1.88B
5.07B
1.97B
Interest expense
-3.03B
-4.14B
-2.97B
-3.10B
Net interest expenses
446.84M
-2.26B
2.10B
-1.13B
Depreciation and amortization charges
474.75M
409.64M
390.19M
397.55M
EBITDA
40.76B
10.58B
31.34B
37.45B
Gain or loss from assets sale
-2.95M
-22.08M
-7.23B
-12.84M
AI content may include mistakes. Learn more
Google apps